in

New Alzheimer’s Treatment Shows Real Promise in Slowing Cognition Decline Using Antibody in Human Trials

Eli Lilly have said their Alzheimer’s drug showed clinically significant improvements in patient decline in mid-stage, phase-2 human trials.

This post was created with our nice and easy submission form. Create your post!

What do you think?

What do you think?

Study: Exercise prompts muscles to fight inflammation on their own | The Optimist Daily: Making Solutions the News

Magnesium promotes healthy sleep. Here’s four great ways to get it | The Optimist Daily: Making Solutions the News